v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Preferred stock
Series A Preferred Stock
Preferred stock
Series T Preferred Stock
Preferred stock
Series Seed Preferred Stock
Common Stock
Additional Paid-in Capital
Noncontrolling Interest
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2023 $ 5,286,667 $ 983,634 $ 1,706,756 $ 6,971 $ 82,005,447 $ (13,251) $ (44,637,430) $ 45,338,794
Balance at the beginning (in shares) at Dec. 31, 2023 185,440,880 9,642,080 204,810,720 697,085,900        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock       $ 2 201,124     201,126
Sale of Common Stock (in shares)       177,980        
Stock compensation expense         2,666,169     2,666,169
Net income (loss)             (4,020,586) (4,020,586)
Balance at the end at Mar. 31, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 6,973 84,872,740 (13,251) (48,658,016) 44,185,503
Balance at the end (in shares) at Mar. 31, 2024 185,440,880 9,642,080 204,810,720 697,263,880        
Balance at the beginning at Dec. 31, 2023 $ 5,286,667 $ 983,634 $ 1,706,756 $ 6,971 82,005,447 (13,251) (44,637,430) $ 45,338,794
Balance at the beginning (in shares) at Dec. 31, 2023 185,440,880 9,642,080 204,810,720 697,085,900        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock (in shares)               177,980
Offering Costs               $ 0
Net income (loss)               (7,042,730)
Balance at the end at Jun. 30, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 6,979 87,540,794 (13,251) (51,680,160) 43,831,419
Balance at the end (in shares) at Jun. 30, 2024 185,440,880 9,642,080 204,810,720 697,912,240        
Balance at the beginning at Mar. 31, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 6,973 84,872,740 (13,251) (48,658,016) 44,185,503
Balance at the beginning (in shares) at Mar. 31, 2024 185,440,880 9,642,080 204,810,720 697,263,880        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock         350     350
Exercise of stock options       $ 6 13,959     13,965
Exercise of stock options (in shares)       648,360        
Stock compensation expense         2,653,745     2,653,745
Net income (loss)             (3,022,144) (3,022,144)
Balance at the end at Jun. 30, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 6,979 87,540,794 (13,251) (51,680,160) 43,831,419
Balance at the end (in shares) at Jun. 30, 2024 185,440,880 9,642,080 204,810,720 697,912,240        
Balance at the beginning at Dec. 31, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,028 95,543,998 (13,251) (61,174,088) 42,340,744
Balance at the beginning (in shares) at Dec. 31, 2024 185,440,880 9,642,080 204,810,720 702,861,520        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock       $ 19 2,125,007     2,125,026
Sale of Common Stock (in shares)       1,922,194        
Offering Costs         (1,444,755)     (1,444,755)
Stock compensation expense         2,651,080     2,651,080
Net income (loss)             1,717,451 1,717,451
Balance at the end at Mar. 31, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,047 98,875,330 (13,251) (59,456,637) 47,389,546
Balance at the end (in shares) at Mar. 31, 2025 185,440,880 9,642,080 204,810,720 704,783,714        
Balance at the beginning at Dec. 31, 2024 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,028 95,543,998 (13,251) (61,174,088) $ 42,340,744
Balance at the beginning (in shares) at Dec. 31, 2024 185,440,880 9,642,080 204,810,720 702,861,520        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock (in shares)               7,664,037
Offering Costs               $ (5,584,525)
Net income (loss)               4,995,352
Balance at the end at Jun. 30, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,286 103,673,693 (13,251) (56,178,736) 55,466,049
Balance at the end (in shares) at Jun. 30, 2025 185,440,880 9,642,080 204,810,720 728,767,714        
Balance at the beginning at Mar. 31, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,047 98,875,330 (13,251) (59,456,637) 47,389,546
Balance at the beginning (in shares) at Mar. 31, 2025 185,440,880 9,642,080 204,810,720 704,783,714        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Sale of Common Stock       $ 57 6,305,843     6,305,900
Sale of Common Stock (in shares)       5,741,843        
Exercise of stock options       $ 182 105,852     106,034
Exercise of stock options (in shares)       18,242,157        
Offering Costs         (4,139,770)     (4,139,770)
Stock compensation expense         2,526,438     2,526,438
Net income (loss)             3,277,901 3,277,901
Balance at the end at Jun. 30, 2025 $ 5,286,667 $ 983,634 $ 1,706,756 $ 7,286 $ 103,673,693 $ (13,251) $ (56,178,736) $ 55,466,049
Balance at the end (in shares) at Jun. 30, 2025 185,440,880 9,642,080 204,810,720 728,767,714